Status:

RECRUITING

Seated Balance Using the Indego™

Lead Sponsor:

James J. Peters Veterans Affairs Medical Center

Conditions:

Spinal Cord Injuries

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Exoskeleton-assisted walking (EAW) provides a new mobility option and appears to have potential therapeutic benefits for persons with SCI. However, present day technology is not sufficient to replace ...

Detailed Description

Introduction/Background: People with spinal cord injury (SCI) can lose partial to complete voluntary control of arm, trunk and leg muscles, resulting in an inability to sit with stability, stand and/o...

Eligibility Criteria

Inclusion

  • Traumatic or non-traumatic SCI ≥6 months duration of SCI;
  • Wheelchair-user for indoor and outdoor mobility;
  • Level and completeness of injury T4 and below with complete or incomplete SCI (ISNCSCI A to D);
  • Able to hold the crutches in hands with or without modifications; and
  • Able to provide informed consent.

Exclusion

  • Diagnosis of neurological injury other than SCI;
  • Progressive condition that would be expected to result in changing neurological status;
  • Severe concurrent medical disease, illness or condition judged to be contraindicated by the Site Physician;
  • Anthropocentric incompatibility to be fitted with the device;
  • Traumatic or high impact lower extremity fracture within the past 2 years;
  • Fragility, minimal trauma or low impact fracture of the lower extremity since spinal cord injury;
  • Knee BMD \< 0.60 gm/cm2;
  • Total hip BMD T-scores \< -3.5;
  • Untreatable severe spasticity judged to be contraindicated by the Site Physician;
  • Flexion contracture that is incompatible with the device;
  • Limitations in ankle range of motion that cannot be adapted with an orthotic device (plantar flexion \> 00);
  • Fracture of the foot by x-ray and confirmed by CT;
  • Untreated or uncontrolled hypertension (systolic blood pressure \>140 mmHg; diastolic blood pressure \>90 mmHg);
  • Unresolved orthostatic hypotension (systolic blood pressure \<90 mmHg; diastolic blood pressure \<60 mmHg) as judged to be contraindicated by the Site Physician;
  • Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities;
  • History of seizure;
  • Use of medications that significantly lower seizure threshold, such as tricyclic antidepressants, amphetamines, neuroleptics, dalfampridine, and bupropion;
  • History of stroke, brain tumor, brain abscess, or multiple sclerosis;
  • History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging);
  • History of implanted brain/spine/nerve simulators, aneurysm clips, ferromagnetic metallic implants, or cardiac pacemaker/defibrillator;
  • Psychopathology documentation in the medical record or history that may conflict with study objectives; and/or
  • Pregnancy or women who plan to become pregnant during the study period.

Key Trial Info

Start Date :

February 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04047992

Start Date

February 1 2018

End Date

December 31 2025

Last Update

May 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

James J. Peters VA Medical Center

The Bronx, New York, United States, 10468

Seated Balance Using the Indego™ | DecenTrialz